Assessment of ARX expression, a novel biomarker for metastatic risk in pancreatic neuroendocrine tumors, in endoscopic ultrasound fine‐needle aspiration

BACKGROUND: The transcription factors ARX and PDX1, and alternative lengthening of telomeres (ALT) were recently described as prognostic markers for resected non‐functional pancreatic neuroendocrine tumors (PanNETs). ALT positive tumors with ARX expression relapse most often. Currently, tumor size i...

Descripción completa

Detalles Bibliográficos
Autores principales: Hackeng, Wenzel M., Morsink, Folkert H. M., Moons, Leon M. G., Heaphy, Christopher M., Offerhaus, G. Johan A., Dreijerink, Koen M. A., Brosens, Lodewijk A. A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley & Sons, Inc. 2019
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7079001/
https://www.ncbi.nlm.nih.gov/pubmed/31846235
http://dx.doi.org/10.1002/dc.24368

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7079001/
https://www.ncbi.nlm.nih.gov/pubmed/31846235
http://dx.doi.org/10.1002/dc.24368

Ejemplares similares